MA H1240

Caps out-of-pocket insulin costs at $100 per 30-day supply for individuals covered by state employee insurance, Medicaid, and private health plans (including HMOs and PPOs), regardless of insulin type or quantity needed

Requires insulin manufacturers with Medicaid drug rebate agreements to offer a one-time annual 30-day supply of insulin at no cost to individuals who urgently need it (defined as having less than 7 days supply and at risk of rationing)

Establishes eligibility for manufacturer patient assistance programs: U.S. citizens or legal residents with household income at or below 400% of federal poverty level who lack private prescription drug coverage and are not eligible for federal drug benefits (except Medicare Part D enrollees may qualify)

Mandates manufacturers respond to assistance program applications within 14 days and enroll eligible applicants for 1 year

Imposes $100,000 per month fine on pharmaceutical manufacturers that fail to comply with patient assistance program requirements